Robert Landry
Director of Finance/CFO chez CHECKMATE PHARMACEUTICALS, INC.
Fortune : 16 M $ au 31/03/2024
Postes actifs de Robert Landry
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CHECKMATE PHARMACEUTICALS, INC. | Director of Finance/CFO | 31/05/2022 | - |
| DECIBEL THERAPEUTICS, INC. | Director of Finance/CFO | 22/09/2023 | - |
Historique de carrière de Robert Landry
Anciens postes connus de Robert Landry
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| REGENERON PHARMACEUTICALS, INC. | Director of Finance/CFO | 03/10/2013 | 05/02/2024 |
| Corporate Officer/Principal | 09/09/2013 | 03/10/2013 | |
| PFIZER, INC. | Corporate Officer/Principal | 01/10/2009 | 01/10/2012 |
| Treasurer | 01/10/2012 | 01/08/2013 | |
Wyeth Corp.
 Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Treasurer | 01/01/2007 | 01/10/2009 |
| Wyeth Australia Pty Ltd. | Director of Finance/CFO | 01/01/2004 | 01/01/2006 |
| Sales & Marketing | 01/01/2006 | 01/01/2007 | |
| Wyeth New Zealand | Director of Finance/CFO | 01/04/2004 | 01/01/2006 |
Formation de Robert Landry
| University of Notre Dame | Undergraduate Degree |
Statistiques
Internationale
| Etats-Unis | 7 |
| Australie | 2 |
| Nouvelle-Zélande | 2 |
Opérationnelle
| Director of Finance/CFO | 5 |
| Treasurer | 2 |
| Corporate Officer/Principal | 2 |
Sectorielle
| Health Technology | 6 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| PFIZER, INC. | Health Technology |
| REGENERON PHARMACEUTICALS, INC. | Health Technology |
| DECIBEL THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 4 |
|---|---|
Wyeth Corp.
Wyeth Corp. Pharmaceuticals: MajorHealth Technology Wyeth LLC develops, manufactures, and distributes pharmaceuticals and biological substances. The company was founded in 1926 and is headquartered in Madison, NJ. | Health Technology |
| Wyeth Australia Pty Ltd. | |
| Wyeth New Zealand | |
Checkmate Pharmaceuticals, Inc.
 Checkmate Pharmaceuticals, Inc. BiotechnologyHealth Technology Checkmate Pharmaceuticals, Inc. is a clinical-stage biotechnology company, which engages in developing and commercializing proprietary technology to harness the power of the immune system to combat cancer. The firm's product candidate, vidutolimod is a differentiated TLR9 agonist delivered as a biologic virus-like particle designed to trigger the body's innate immune system to attack tumors in combination with other therapies. The company was founded by Arthur M. Krieg and Chuck Yo in July 2015 and is headquartered in Cambridge, MA. | Health Technology |
- Bourse
- Insiders
- Robert Landry
- Expérience
